Microbot Medical receives patents in multiple jursidictions

Microbot Medical announced that it has received patents in multiple jurisdictions. The Company now has 40 issued/allowed patents and 23 patent applications pending worldwide. The U.S. Patent and Trademark Office issued a Notice of Allowance 684 pertaining to the Company's Self-Cleaning Shunt device. The allowed patent application is a Continuation of a patent, issued on July 19, 2016, and covers a device for mitigating occlusion in an implantable catheter. The claims are directed to a device comprising a tube having at least one drainage opening disposed in its wall and configured for implantation within a body cavity, further comprising a cleaning element having at least one cleaning protrusion extending into the opening and configured to move within the opening. Additionally, the European Patent Office granted an EP Patent covering the Company's guidewire technology for use with endo-luminal interventions, and related to the Company's LIBERTY development. This is the second European patent granted for this unique technology and extends protection to include the device's current development, having a double guidewire comprising a first hollow guidewire and a second guidewire deployed within the first guidewire, and an adjuster mechanism operable to displace the second guidewire longitudinally relative to the first guidewire between at least three states.